相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。T cell engineered with a novel nanobody-based chimeric antigen receptor against VEGFR2 as a candidate for tumor immunotherapy
Fatemeh Hajari Taheri et al.
IUBMB LIFE (2019)
Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells
Esther Drent et al.
CLINICAL CANCER RESEARCH (2019)
Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice
Yushu Joy Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer
Tiara T. Byrd et al.
CANCER RESEARCH (2018)
Engineering Chimeric Antigen Recptor T-Cells for Racing in Solid Tumors: Don't Forget the Fuel
Melita Irving et al.
FRONTIERS IN IMMUNOLOGY (2017)
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
Rakesh R. Ramjiawan et al.
ANGIOGENESIS (2017)
T Cells Bearing a Chimeric Antigen Receptor against Prostate-Specific Membrane Antigen Mediate Vascular Disruption and Result in Tumor Regression
Stephen P. Santoro et al.
CANCER IMMUNOLOGY RESEARCH (2015)
The Great Escape; the Hallmarks of Resistance to Antiangiogenic Therapy
Judy R. van Beijnum et al.
PHARMACOLOGICAL REVIEWS (2015)
Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice
Dhanalakshmi Chinnasamy et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
分享论文
